Additionally, DNMT3A mutations promote Twist family bHLH transcription factor 1 (TWIST1) expression, facilitating extramedullary infiltration of AML cells, thereby compromising treatment efficacy [38]. The gene discussed is TWIST1; the disease is acute myeloid leukemia.